文献速递胰腺与胆道疾病消化内镜

症状性胆石症中等概率胆总管结石诊断策略的成本效果分析

Cost-effectiveness analysis of optimal diagnostic strategy for patients with symptomatic cholelithiasis with intermediate probability for choledocholithiasis.
PubMed 文献 · Gastrointest Endosc · 2021-09-06

研究建立决策树比较腹腔镜胆囊切除联合术中胆道造影(LC-IOC)、MRCP、单次EUS+ERCP和分开EUS+ERCP四种策略诊断中等概率胆总管结石的成本效果。结果显示LC-IOC最具成本效果,净货币效益为34612美元,每次真阳性诊断平均成本13260美元,平均住院日4.13天,敏感性分析稳健。

要点

  • 对胆石症合并中等概率胆总管结石患者,LC-IOC是最具成本效果的诊断策略。
  • LC-IOC的净货币效益为34612美元,每真阳性诊断平均成本13260美元。
  • LC-IOC平均住院日为4.13天,优于其他策略,且敏感性分析结果稳健。

核心结论

  • 对于胆石症合并中等概率胆总管结石患者,LC-IOC是成本效果最优的策略,可限制术前检查并可能缩短住院时间。

研究设计与样本

  • 研究构建决策树模型,设定胆总管结石中等概率基础值为50%(范围10%-70%),阳性者模拟接受治疗性ERCP。
  • 比较策略包括腹腔镜胆囊切除联合术中胆道造影(LC-IOC)、MRCP、单次EUS+ERCP和分开EUS+ERCP。
  • 成本和概率数据提取自已发表文献,效果评估采用健康状态效用评分、真阳性诊断平均比例和平均住院日。

主要发现

  • 在健康状态效用分析中,LC-IOC的净货币效益为34612美元,优于MRCP、单次EUS+ERCP和分开EUS+ERCP。
  • 在诊断准确性分析中,LC-IOC每真阳性诊断平均成本为13260美元,低于其他策略。
  • 在住院日分析中,LC-IOC平均住院日为4.13天,短于其他策略。
  • 确定性和概率敏感性分析均显示上述结果稳健。

关键数值与推荐

  • 胆总管结石中等概率基础值为50%,范围10%-70%。
  • LC-IOC净货币效益34612美元,每真阳性诊断平均成本13260美元,平均住院日4.13天。

临床怎么用

  • 对于胆石症合并中等概率胆总管结石患者,可优先考虑LC-IOC策略以减少术前检查并可能缩短住院时间。
  • 研究结果可用于设计机构和管理协议。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: EUS, MRCP, and intraoperative cholangiogram (IOC) are the recommended diagnostic modalities for patients with intermediate probability for choledocholithiasis (IPC). The relative cost-effectiveness of these modalities in patients with cholelithiasis and IPC is understudied. METHODS: We developed a decision tree for diagnosing IPC (base-case probability, 50%; range, 10%-70%); patients with a positive test were modeled to undergo therapeutic ERCP. The strategies tested were laparoscopic cholecystectomy with IOC (LC-IOC), MRCP, single-session EUS + ERCP, and separate-session EUS + ERCP. Costs and probabilities were extracted from the published literature. Effectiveness was assessed by assigning utility scores to health states, average proportion of true-positive diagnosis of IPC, and the mean length of stay (LOS) per strategy. Cost-effectiveness was assessed by extrapolating a net-monetary benefit (NMB) and average cost per true-positive diagnosis. RESULTS: LC-IOC was the most cost-effective strategy to diagnose IPC (base-case probability of 50%) among patients with cholelithiasis in health state-based effectiveness analysis (NMB of $34,612), diagnostic test accuracy-based effectiveness analysis (average cost of $13,260 per true-positive diagnosis), and LOS-based effectiveness analysis (mean LOS of 4.13) compared with strategies 2 (MRCP), 3 (single-session EUS + ERCP), and 4 (separate-session EUS + ERCP). These findings were robust on deterministic and probabilistic sensitivity analyses. CONCLUSIONS: For patients with cholelithiasis with IPC, LC-IOC is a cost-effective approach that should limit preoperative testing and may shorten hospital LOS. Our findings may be used to design institutional and organizational management protocols.

来源:Gastrointest Endosc,查看原文。版权归原作者所有。

引用

  1. Ali FS, DaVee T, Bernstam EV, et al. Cost-effectiveness analysis of optimal diagnostic strategy for patients with symptomatic cholelithiasis with intermediate probability for choledocholithiasis. Gastrointest Endosc. 2021. PMID: 34499905. doi:10.1016/j.gie.2021.08.024

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。